These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26123413)

  • 1. Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable: an illustrative case study of cancer risk of patients on glucose-lowering therapies.
    Ng ES; Klungel OH; Groenwold RH; van Staa TP
    Pharm Stat; 2015; 14(5):382-94. PubMed ID: 26123413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to control for unmeasured confounding in an observational time-to-event study with exposure incidence information: the treatment choice Cox model.
    Troendle J; Leifer E; Zhang Z; Yang S; Tewes H
    Stat Med; 2017 Oct; 36(23):3654-3669. PubMed ID: 28675922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.
    Pazzagli L; Linder M; Zhang M; Vago E; Stang P; Myers D; Andersen M; Bahmanyar S
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):148-160. PubMed ID: 29285840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.
    Martinuka O; von Cube M; Wolkewitz M
    Clin Microbiol Infect; 2021 Jul; 27(7):949-957. PubMed ID: 33813117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.
    Daniel S; Koren G; Lunenfeld E; Levy A
    Am J Obstet Gynecol; 2015 Mar; 212(3):307.e1-6. PubMed ID: 25265406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment.
    Xu S; Shetterly S; Raebel MA; Ho PM; Tsai TT; Magid D
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):812-8. PubMed ID: 24596337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
    Mamtani R; Haynes K; Bilker WB; Vaughn DJ; Strom BL; Glanz K; Lewis JD
    J Natl Cancer Inst; 2012 Sep; 104(18):1411-21. PubMed ID: 22878886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model.
    Ng'andu NH
    Stat Med; 1997 Mar; 16(6):611-26. PubMed ID: 9131751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of methods to estimate the hazard ratio under conditions of time-varying confounding and nonpositivity.
    Naimi AI; Cole SR; Westreich DJ; Richardson DB
    Epidemiology; 2011 Sep; 22(5):718-23. PubMed ID: 21747286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study.
    De Bruijn KM; Ruiter R; de Keyser CE; Hofman A; Stricker BH; van Eijck CH
    Eur J Cancer; 2014 Sep; 50(14):2449-55. PubMed ID: 25047425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling for confounding via propensity score methods can result in biased estimation of the conditional AUC: A simulation study.
    Galadima HI; McClish DK
    Pharm Stat; 2019 Oct; 18(5):568-582. PubMed ID: 31111682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
    Kowall B; Rathmann W; Kostev K
    Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bias from outcome misclassification in immunization schedule safety research.
    Newcomer SR; Kulldorff M; Xu S; Daley MF; Fireman B; Lewis E; Glanz JM
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):221-228. PubMed ID: 29292551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
    Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
    J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.
    Gamble JM; Chibrikov E; Twells LK; Midodzi WK; Young SW; MacDonald D; Majumdar SR
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):43-52. PubMed ID: 27865756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events.
    Tamblyn R; Girard N; Dixon WG; Haas J; Bates DW; Sheppard T; Eguale T; Buckeridge D; Abrahamowicz M; Forster A
    J Clin Epidemiol; 2016 Sep; 77():101-111. PubMed ID: 27212138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.